Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Music processing in behavioural variant frontotemporal dementia and Alzheimer's disease: a functional MRI study.

Brain communications·2026
Same author

Smartphone-based detection of subtle memory decline in prodromal Alzheimer's disease.

NPJ digital medicine·2026
Same author

Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment.

The journal of prevention of Alzheimer's disease·2026
Same author

Minor neuropsychological deficits and stage 2 of Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Non-economic social deprivation and cognitive functioning later in life: Results from the DELCODE study.

Journal of Alzheimer's disease : JAD·2026
Same author

Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.

Annals of neurology·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Cardiovascular-kidney-metabolic syndrome stage modifies the efficacy of intensive blood pressure control on cognitive outcomes: A post hoc analysis of SPRINT MIND.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evidence of APOE4-related brain vulnerabilities in verbal memory systems in midlife women.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Changes in DNA methylation-based aging predicts brain damage and dementia and reflects life-course cardiovascular risk.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Elimination of tau tangles and soluble aggregates with the small molecule ACI-16664 prevents neurodegeneration in vivo.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Altered brain glucose metabolism and connectivity in young adults with obstructive sleep apnea.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章
  1. 首页
  3. 生物标志物 生物标志物
  1. 首页
  3. 生物标志物 生物标志物

相关实验视频

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Marianna Rizzo1, Charlotte E Teunissen2, Frederic Brosseron3

  • 1Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025

在PubMed 上查看摘要

概括
此摘要是机器生成的。

补体系统参与神经退行性疾病,如阿尔茨海默氏症和帕金森症. 补充因子与关键生物标志物 (如粉样蛋白和α-synuclein) 联系在一起,表明其在疾病病理学中的作用.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 生物化学 生物化学

背景情况:

  • 补充系统在神经退行性疾病 (如阿尔茨海默氏症 (AD),勒维体痴呆症 (DLB) 和帕金森病 (PD) 中的作用已被建议但尚未完全理解.
  • 在脑脊液 (CSF) 中补充因子和核心疾病生物标志物 (粉样蛋白,,NfL,α-synuclein) 之间的关联需要进一步调查.

研究的目的:

  • 研究脑脊液补充因子和已确定的神经退行生物标志物 (氨基酸-β42/40比,酸化181,神经丝光链和α-synuclein) 之间的关系.
  • 探索AD,DLB,PD和对照组中补充因子的潜在疾病特异性关联.

主要方法:

  • 来自EPND研究的321名参与者 (AD,DLB,PD,对照) 的CSF样本的分析.
  • 在CSF生物标志物 (Aβ42/40,p-tau181,NfL,α-syn) 和14个补充因子的量化.
  • 根据年龄和性别调整的线性回归模型,根据迷你心理状态检查 (MMSE) 成绩进行后期分析.

主要成果:

  • 补充因子显示了不同疾病与生物标志物的差异关联.
  • 粉样蛋白-β 42/40 水平与对照组和AD中的特定补充因子相关,但没有DLB或PD.
  • 酸化的tau 181,NfL和α-synuclein与补充因子具有更广泛的关联,在PD中观察到对α-synuclein的一些特定疾病模式.

结论:

  • 脑脊液补充因子与关键的神经退行性生物标志物有关,支持补充系统参与AD,DLB和PD.
  • 在AD中确定了补充剂和粉样蛋白之间的疾病特异性关系,在PD中确定了补充剂和α-synuclein之间的疾病特异性关系.